Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization testKASSAI, Ferenc; GYERTYAN, István.Progress in neuro-psychopharmacology & biological psychiatry. 2012, Vol 36, Num 1, pp 128-135, issn 0278-5846, 8 p.Article

Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezingINOUE, Takeshi; NAKAGAWA, Shin; IZUMI, Takeshi et al.European journal of pharmacology. 2006, Vol 540, Num 1-3, pp 91-95, issn 0014-2999, 5 p.Article

Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitorsOHNO, Yukihiro; HIBINO, Hiroshi; LOSSIN, Christoph et al.Brain research. 2007, Vol 1178, pp 44-51, issn 0006-8993, 8 p.Article

Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivityDE JONG, Trynke R; PATTIJ, Tommy; VEENING, Jan G et al.European journal of pharmacology. 2005, Vol 509, Num 1, pp 49-59, issn 0014-2999, 11 p.Article

Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdalaINOUE, Takeshi; LI, Xiao Bai; ABEKAWA, Tomohiro et al.European journal of pharmacology. 2004, Vol 497, Num 3, pp 311-316, issn 0014-2999, 6 p.Article

Integrative physiology of depression and antidepressant drug action: Implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depressionHALE, Matthew W; RAISON, Charles L; LOWRY, Christopher A et al.Pharmacology & therapeutics (Oxford). 2013, Vol 137, Num 1, pp 108-118, issn 0163-7258, 11 p.Article

Toxicity and hazard of a mixture of SSRIs to zooplankton communities evaluated in aquatic microcosmsLAIRD, Brian D; BRAIN, Richard A; JOHNSON, David J et al.Chemosphere (Oxford). 2007, Vol 69, Num 6, pp 949-954, issn 0045-6535, 6 p.Article

Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake InhibitorsNELSON, Elana M; PHILBRICK, Ann M.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1712-1716, issn 1060-0280, 5 p.Article

Role of fluoxetine in anorexia nervosaKIM, Sara S.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 890-892, issn 1060-0280, 3 p.Article

What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?DEMYTTENAERE, Koen; ALBERT, Adelin; MESTERS, Patrick et al.The Journal of clinical psychiatry. 2005, Vol 66, Num 7, pp 859-863, issn 0160-6689, 5 p.Article

Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical EvidenceOBERLANDER, T. F; GINGRICH, J. A; ANSORGE, M. S et al.Clinical pharmacology and therapeutics. 2009, Vol 86, Num 6, pp 672-677, issn 0009-9236, 6 p.Article

Facilitation of Serotonin Signaling by SSRIs is Attenuated by Social IsolationDANKOSKI, Elyse C; AGSTER, Kara L; FOX, Megan E et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 13, pp 2928-2937, issn 0893-133X, 10 p.Article

Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response : A Naturalistic StudyPUNDIAK, Tara M; CASE, Brady G; PESELOW, Eric D et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 11, pp 1811-1817, issn 0160-6689, 7 p.Article

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice : tapering versus abrupt discontinuationVAN GEFFEN, E. C. G; HUGTENBURG, J. G; HEERDINK, E. R et al.European journal of clinical pharmacology. 2005, Vol 61, Num 4, pp 303-307, issn 0031-6970, 5 p.Article

Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) et ostéoporose : Ostéoporose = Selective serotonin reuptake inhibitors (SSRI) and osteoporosisFETIQUE-WILL, A.-C; CHEVALLEY, T; RIZZOLI, R et al.Revue médicale suisse. 2011, Vol 7, Num 299, pp 1299-1304, issn 1660-9379, 6 p.Article

How often do ssris and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is lowZIMMERMAN, Mark; THONGY, Tavi.The Journal of clinical psychiatry. 2007, Vol 68, Num 8, pp 1271-1276, issn 0160-6689, 6 p.Article

Ninety-three cases of alcohol dependence following SSRI treatmentBROOKWELL, Louise; HOGAN, Carys; HEALY, David et al.International journal of risk & safety in medicine. 2014, Vol 26, Num 2, pp 99-107, issn 0924-6479, 9 p.Article

The risk of suicide with selective serotonin reuptake inhibitors in the elderlyJUURLINK, David N; MAMDANI, Muhammad M; KOPP, Alexander et al.The American journal of psychiatry. 2006, Vol 163, Num 5, pp 813-821, issn 0002-953X, 9 p.Article

Maternal Use of Selective Serotonin Reuptake Inhibitors, Fetal Growth, and Risk of Adverse Birth OutcomesEL MARROUN, Hanan; JADDOE, Vincent W. V; HUDZIAK, James J et al.Archives of general psychiatry. 2012, Vol 69, Num 7, pp 706-714, issn 0003-990X, 9 p.Article

SSRI-associated sexual dysfunctionBALON, Richard.The American journal of psychiatry. 2006, Vol 163, Num 9, pp 1504-1509, issn 0002-953X, 6 p.Article

Selective serotonin reuptake inhibitors in autism : A review of efficacy and tolerabilityKOLEVZON, Alexander; MATHEWSON, Karen A; HOLLANDER, Eric et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 3, pp 407-414, issn 0160-6689, 8 p.Article

Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant SyndromeSTEVENS, Debra L.The Annals of pharmacotherapy. 2008, Vol 42, Num 9, pp 1290-1297, issn 1060-0280, 8 p.Article

ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathwayPOWELL, Timothy R; TANSEY, Katherine E; BREEN, Gerome et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 7, pp 609-615, issn 0269-8811, 7 p.Article

Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophoresDIERS, Jeffrey A; IVEY, Kelly D; EL-ALFY, Abir et al.Pharmacology, biochemistry and behavior. 2008, Vol 89, Num 1, pp 46-53, issn 0091-3057, 8 p.Article

Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algaeJOHNSON, David J; SANDERSON, Hans; BRAIN, Richard A et al.Ecotoxicology and environmental safety (Print). 2007, Vol 67, Num 1, pp 128-139, issn 0147-6513, 12 p.Article